Akebia Therapeutics Inc.
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Akebia Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Akebia Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
The Principal Healthcare ETF Thriving under Vaccine Progress via ETF TrendsTenet Healthcare Corp's (THC) CEO Ron Rittenmeyer on Q3 2020 Results - Earnings Call Transcript via Seeking Alpha
Prelude Therapeutics started at equal weight at Morgan Stanley via MarketWatch
Akebia Therapeutics Inc. Performance
Active Alerts for IEX:AKBA
You don't have any alerts set for IEX:AKBA.
About Akebia Therapeutics Inc.
Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology.
Real-time AKBA to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.